date:Aug 14, 2014
istrations Guidance for Industry #213, which phases out the use of antibiotics to promote growth in food animals.
Critics of the guidance say that it wont actually do much to reduce the use of these drugs because disease prevention labels could simply replace those for growth promotion. They emphasize that the antibiotic manufacturers have stated that they dont expect the change to affect their revenues.
It shares the central flaw of the FDA guidance on which it is modeled: it would allow most